{"doi":"10.31235/osf.io/dhk5x","title":"Attitudes in 2020 towards medical and recreational marijuana in prohibitionist Nebraska","abstract":"Background - Despite considerable change in the legal status of marijuana in the United States in the 21st century, the state of Nebraska has seen very little legislative movement. With no legal allowances for medical or recreational use of marijuana, Nebraska has become an outlier in maintaining a complete prohibition on the substance. We examine overall public support for medical and recreational marijuana in the state of Nebraska, as well as support by intrastate region, political party, and the association between stigma and legal support.Methods - We use data from the 2020 Nebraska Annual Social Indicators Survey (NASIS) which is paper survey mailed to an address-based sample of Nebraskans who are 19 and older. The 2020 NASIS was mailed to 8,000 addresses in Nebraska using a stratified sampling design. Using a question developed by Pew Research Center we ask if participants support legal marijuana for medical AND recreational use, medical use only, or if they think it should not be legal. Results – We estimate that 83% of Nebraskans support medical marijuana legalization, a clear majority of opinion. Support is more divided between whether the substance should be legal for both medical and recreational use, or just for medical use. There are also associations between support preferences and age, political party, gender, and the amount of stigma a participant reports in their community towards people that use various substances.Conclusion – A small percent of the Nebraska population are estimated to favor keeping marijuana illegal. The current legislative prohibition is out of step with public opinion in the state, suggesting that ballot initiatives will likely find success in the state should current legislation fail.","journal":"SocArXiv (OSF Preprints)","year":2021,"id":228723,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9581,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2021-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":450960,"name":"Rick A. Bevins","orcid":"0000-0002-2438-2264","position":1,"is_corresponding":false},{"id":426509,"name":"Patrick Habecker","orcid":"0000-0003-4435-1593","position":0,"is_corresponding":true}],"reference_count":21,"raw_metadata":{"citation_network_status":"fetched"},"created_at":"2026-07-18T23:54:54.016932Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}